Estrogen-Mediated Protection in Myocardial Ischemia-Reperfusion Injury
Authors:
- 6 August 2008
- journal article
- review article
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 8 (3) , 101-113
Abstract
Before menopause, a woman has a relatively low risk for developing cardiovascular disease. After menopause, however, the risk increases nearly twofold and cardiovascular disease remains the number one cause of death among women. Observational trials and studies in animal models of cardiovascular disease suggested that females have reduced injury after myocardial ischemia and reperfusion injury. However, two large clinical trials, the women’s health initiative (WHI) and the heart estrogen and progestin replacement study (HERS), found an increase in cardiovascular incidences in women taking hormone replacement therapy. The discrepancy between these data highlights the need for further research on the mechanism of estrogen in the cardiovascular system. Animal studies have demonstrated protective effects by endogenous estrogen (gender differences) and also by the administration of exogenous estrogen. In vivo studies suggest a possible anti-inflammatory mechanism of estrogen. Exogenous estrogen has been shown to have anti-oxidant activities. Pre-treatment with estrogen prior to myocardial ischemia and reperfusion causes a decrease in neutrophil infiltration into the irreversibly injured myocardium, decrease in C-reactive protein expression, and deposition of the membrane attack complex. This review will summarize the protection afforded by estrogen as well as discuss several possible mechanisms of protection for exogenous estrogen administration.Keywords
This publication has 120 references indexed in Scilit:
- Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipidsBreast Cancer Research and Treatment, 2004
- Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal womenAmerican Heart Journal, 2004
- S-palmitoylation modulates human estrogen receptor-α functionsBiochemical and Biophysical Research Communications, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Estrogen Inhibits Phorbol Ester-Induced IκBα Transcription and Protein DegradationBiochemical and Biophysical Research Communications, 1998
- Estradiol Down‐Regulates LPS‐Induced Cytokine Production and NFkB Activation in Murine MacrophagesAmerican Journal of Reproductive Immunology, 1997
- Regression of Atherosclerosis in Female MonkeysArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Prostaglandin endoperoxide synthase: regulation of enzyme expressionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985